Diclofenac Topical (arthritis pain)
Diclofenac topical gel is a prescription anti-inflammatory applied directly to the skin to relieve osteoarthritis pain in the knees and hands.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Diclofenac gel is a prescription NSAID (anti-inflammatory) rubbed onto osteoarthritic knees and hands, where it blocks the COX enzyme that makes prostaglandins (the chemicals behind pain and swelling), and it is a common first choice for those joints because far less drug reaches the bloodstream than with NSAIDs taken by mouth. Most people tolerate it well, and side effects usually stay on the skin as redness, itching, dryness or a rash where it is applied. It still carries the boxed warning all NSAIDs share for heart attack, stroke and stomach or intestinal bleeding, which can be fatal, so use the smallest amount that helps for the shortest time.
Clinical pearls
- Measure each dose on the dosing card in the box, and wait at least an hour before washing treated hands.
- It is meant for knees and hands, and it has not been studied for the hip, shoulder or spine.
- Tell every prescriber you use it, since it adds bleeding risk with warfarin or aspirin and can raise lithium levels.
- If you take a water pill or an ACE inhibitor, your kidney function should be checked while using this gel.
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
This medication carries a serious FDA boxed warning — the strongest warning the FDA can require.
Heart risk: NSAIDs, including this gel, can increase the risk of heart attack and stroke, which can be fatal. This risk may increase the longer you use it. People who already have heart disease are most at risk. This medication must not be used around the time of coronary artery bypass graft (CABG) heart surgery.
Stomach and intestinal risk: This gel can cause serious bleeding, ulcers, or tears in the stomach or intestines that can also be fatal — and may happen without any warning signs. Older adults face a higher risk of these serious gut problems. Watch for stomach pain, black or tarry stools, or vomiting blood, and get medical help right away if any of these occur.
Patient information guide A plain-language walkthrough of Diclofenac Topical (arthritis pain), written from its FDA label.
What Diclofenac Topical (arthritis pain) is used for
▾
Diclofenac topical gel is used to relieve joint pain caused by osteoarthritis in areas that can be reached through the skin.
- Knees — the most commonly treated joint
- Hands (including fingers, palm, and back of the hand)
- Wrists
- Ankles and feet
- Elbows
Not studied or recommended for the spine, hip, or shoulder.
How Diclofenac Topical (arthritis pain) works
▾
Diclofenac is an NSAID that works by blocking an enzyme called cyclooxygenase (COX). This enzyme is a key step in your body's production of prostaglandins — chemicals that signal pain, promote swelling, and drive inflammation. By blocking COX at the site where you apply the gel, diclofenac reduces those pain and inflammation signals locally in the joint.
Because the gel is applied to the skin rather than swallowed, much less of the drug reaches your bloodstream compared to an oral NSAID — roughly 17 times less with typical use on one knee. This local action is a key reason the topical form is used for accessible joints.
Diclofenac Topical (arthritis pain) dosage
▾
Apply the gel to the affected joint four times daily, gently massaging it into the entire area. Use the dosing card included in the box to measure the right amount each time — lower-extremity joints like the knee get a larger measured dose, and upper-extremity joints like the wrist or hand get a smaller one.
- Do not exceed the daily limit for any single joint
- Do not exceed the total daily limit across all treated joints
- If treating your hands, wait at least one hour before washing them
- Rinse and dry the dosing card after each use
Always follow your prescriber's specific instructions. This medication does not need to be taken with food since it is not swallowed.
Dosing details from the FDA-approved label
From the Diclofenac Topical (arthritis pain) prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
Total dose should not exceed 32 g per day, over all affected joints.
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION Total dose should not exceed 32 g per day, over all affected joints. ( 2.3 ) Diclofenac sodium topical gel should be measured onto the enclosed dosing card to the appropriate 2 g or 4 g designation. ( 2 ) • Lower extremities: Apply the gel (4 g) to the affected area 4 times daily. Do not apply more than 16 g daily to any one affected joint of the lower extremities. ( 2.2 ) • Upper extremities: Apply the gel (2 g) to the affected area 4 times daily. Do not apply more than 8 g daily to any one affected joint of the upper extremities. ( 2.3 ) 2.1 Dosing Card [See the patient Instructions for Use] The dosing card can be found attached to the inside of the carton. The proper amount of diclofenac sodium topical gel should be measured using the dosing card supplied in the drug product carton. The dosing card is made of clear polypropylene. The dosing card should be used for each application of drug product. The gel should be applied within the rectangle area of the dosing card up to the 2 gram or 4 gram line (2 g for each elbow, wrist, or hand, and 4 g for each knee, ankle, or foot). The 2 g line is 2.25 inches long. The 4 g line is 4.5 inches long. The dosing card containing diclofenac sodium topical gel can be used to apply the gel. The hands should then be used to gently rub the gel into the skin. After using the dosing card, hold with fingertips, rinse, and dry. If treatment site is the hands, patients should wait at least one (1) hour to wash their hands. 2.2 Lower extremities, including the knees, ankles, and feet Apply the gel (4 g) to the affected foot or knee or ankle, 4 times daily. Diclofenac sodium topical gel should be gently massaged into the skin ensuring application to the entire affected foot, or knee or ankle. The entire foot includes the sole, top of the foot and the toes. Do not apply more than 16 g daily to any single joint of the lower extremities. 2.3 Upper extremities including the elbows, wrists, and hands Apply the gel (2 g) to the affected hand or elbow or wrist, 4 times daily. Diclofenac sodium topical gel should be gently massaged into the skin ensuring application to the entire affected hand or elbow or wrist. The entire hand includes the palm, back of the hands, and the fingers. Do not apply more than 8 g daily to any single joint of the upper extremities.
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Diclofenac Topical (arthritis pain) side effects
▾
The most common side effects are reactions right where you apply the gel.
Common side effects
- Skin irritation or dermatitis at the application site
- Redness or rash where the gel is applied
- Dry or scaly skin at the treated area
- Itching at the application site
- Skin discoloration at the treated area
When to get medical help
- Chest pain, shortness of breath, weakness, or slurred speech — signs of a possible heart attack or stroke
- Black, tarry, or bloody stools, or vomiting blood — signs of stomach or intestinal bleeding
- Sudden severe skin reactions such as blistering, peeling, or a spreading rash — stop use immediately
- Signs of a severe allergic reaction: swelling of the face or throat, difficulty breathing, hives
- Unusual weight gain, swelling in the legs or ankles, or decreased urination — possible kidney or heart problems
- Yellowing of the skin or eyes, nausea, or upper right belly pain — possible liver problems
- Significant rise in blood pressure
More serious reactions — such as stomach bleeding, chest pain, signs of stroke, severe skin reactions like blistering or peeling, or signs of allergic reaction (throat swelling, trouble breathing) — are less common but require immediate medical attention. Stop using the gel and call your doctor or 911 right away if any of these occur.
Diclofenac Topical (arthritis pain) warnings and precautions
▾
- Heart attack and stroke: All NSAIDs, including this gel, can raise the risk of serious and potentially fatal cardiovascular events. The risk may increase with duration of use. Use the lowest effective amount for the shortest time, especially if you have heart disease or risk factors for it.
- Stomach and intestinal bleeding: Can occur without warning at any time during treatment and can be fatal. Older adults are especially vulnerable. Watch for dark or bloody stools, stomach pain, or vomiting blood.
- Liver effects: Liver enzyme levels may rise during treatment. Stop using and contact your doctor if you develop jaundice (yellowing of skin or eyes) or unexplained abdominal pain.
- Kidney effects: Long-term use can harm the kidneys. Higher risk in older adults, people with kidney or heart problems, and those taking diuretics or ACE inhibitors.
- High blood pressure and fluid retention: Monitor blood pressure during use. Stop use if significant swelling or fluid retention develops.
- Severe skin reactions: Rare but potentially fatal skin conditions (such as Stevens-Johnson Syndrome) can occur. Discontinue immediately if a rash or skin reaction develops.
- Severe allergic reactions: Can occur even without a prior reaction to the drug. Stop use immediately and get emergency help if signs of anaphylaxis appear.
Diclofenac Topical (arthritis pain) interactions
▾
Diclofenac topical gel can interact with several common medications, raising the risk of serious side effects.
- Aspirin: Using both together is generally not recommended — it can increase the risk of GI bleeding and other adverse effects.
- Blood thinners (e.g., warfarin): The combination significantly raises the risk of serious stomach or intestinal bleeding.
- ACE inhibitors (e.g., lisinopril): Diclofenac may reduce their blood-pressure-lowering effect.
- Diuretics (water pills, e.g., furosemide, thiazides): Diclofenac may weaken their effect and increase the risk of kidney problems; kidney function should be watched closely.
- Lithium: Diclofenac can raise lithium blood levels, increasing the risk of lithium toxicity — watch for signs like tremor, confusion, or nausea.
- Methotrexate: Diclofenac may increase methotrexate's toxicity; careful monitoring is needed.
- Cyclosporine: Caution is advised when used together due to potential interaction.
Interactions listed in the FDA-approved label
From the Diclofenac Topical (arthritis pain) prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
7 DRUG INTERACTIONS. Concomitant administration of diclofenac and aspirin is not generally recommended because of the potential of increased adverse effects including increased GI bleeding.
Read the label’s full interactions text
7 DRUG INTERACTIONS • Concomitant administration of diclofenac and aspirin is not generally recommended because of the potential of increased adverse effects including increased GI bleeding. ( 7.1 ) • Concomitant use of anticoagulants and diclofenac have a risk of serious GI bleeding higher than users of either drug alone. ( 7.2 ) 7.1 Aspirin When diclofenac is administered with aspirin, the binding of diclofenac to protein is reduced, although the clearance of free diclofenac is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of diclofenac and aspirin is not generally recommended because of the potential of increased adverse effects. 7.2 Anticoagulants The effects of anticoagulants such as warfarin and NSAIDs on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone. 7.3 ACE-Inhibitors NSAIDs may diminish the antihypertensive effect of angiotensin converting enzyme (ACE) inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors. 7.4 Diuretics Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients. The response has been attributed to inhibition of renal prostaglandin synthesis. During concomitant therapy with NSAIDs, the patient should be observed closely for signs of renal failure [see Warnings and Precautions (5.6)] , as well as to assure diuretic efficacy. 7.5 Lithium NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance. The mean minimum lithium concentration increased 15% and the renal clearance was decreased by approximately 20%. These effects have been attributed to inhibition of renal prostaglandin synthesis by the NSAID.
Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Diclofenac Topical (arthritis pain)
▾
- Allergy to diclofenac, aspirin, or any NSAID: Do not use — serious and potentially fatal allergic reactions have occurred.
- Asthma or allergic reactions triggered by aspirin or NSAIDs: Do not use.
- Recent or upcoming CABG (heart bypass) surgery: This medication is contraindicated around that surgery.
- History of heart disease or risk factors (high blood pressure, high cholesterol, diabetes, smoking): Use with caution and use the lowest effective amount.
- History of stomach ulcers or GI bleeding: Use with caution; inform your prescriber.
- Kidney disease, liver disease, or heart failure: Use with caution; close monitoring needed.
- Taking diuretics or ACE inhibitors: Kidney function should be monitored.
- Pregnancy: Safety has not been established. Avoid in late pregnancy — it may cause premature closure of a vital blood vessel in the baby's heart. Discuss use in any trimester with your doctor.
- Breastfeeding: Unknown if diclofenac passes into breast milk; discuss the risks and benefits with your doctor before using.
- Children: Safety and effectiveness in patients under 18 have not been established.
- Older adults: At higher risk for serious GI events and kidney effects — use with extra caution.
Diclofenac Topical (arthritis pain) overdose
▾
If a large amount of this gel is accidentally swallowed, symptoms can include drowsiness, nausea, vomiting, and stomach pain — and in serious cases, high blood pressure, kidney failure, or difficulty breathing. If accidental ingestion occurs, call Poison Control immediately at 1-800-222-1222 or go to the nearest emergency room. Do not induce vomiting unless directed to do so by medical personnel.
What Diclofenac Topical (arthritis pain) does in the body
▾
Diclofenac has three main effects in the body: it reduces inflammation, relieves pain (anti-nociception, meaning it lowers the body's pain-signaling activity), and reduces fever (antipyretic). These effects come from its ability to block the production of prostaglandins, thromboxanes, and prostacyclin — chemicals that play a central role in the body's pain and inflammatory responses. When applied to the skin, these effects are concentrated in the local tissues near the treated joint.
How your body processes Diclofenac Topical (arthritis pain)
▾
Because this medication is applied to the skin rather than swallowed, the amount that reaches your bloodstream is dramatically lower than with oral diclofenac — on average about 17 times less with typical single-knee use. In practical terms, blood levels from the gel are a small fraction of what you'd get from taking diclofenac pills. This reduced systemic (whole-body) absorption is one of the key benefits of the topical form. Applying heat to the treated area before using the gel may affect how much is absorbed, so avoid heating pads or hot packs on the application site.
How to store Diclofenac Topical (arthritis pain)
▾
Store at 20°C to 25°C (68°F to 77°F). Store the dosing card with your diclofenac sodium topical gel.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Diclofenac Topical (arthritis pain): pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Diclofenac Topical (arthritis pain) — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is this gel for — can I use it for any joint pain?
▾
How do I actually apply it — do I just squeeze some out?
▾
Is this safer than taking an NSAID pill since it's just on my skin?
▾
What side effects should I actually expect, and what should make me call the doctor?
▾
I take a blood thinner — is it okay to use this gel?
▾
Can I use this if I'm pregnant or breastfeeding?
▾
Is Diclofenac Topical (arthritis pain) available over the counter?
▾
When was Diclofenac Topical (arthritis pain) first available?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Diclofenac Topical (arthritis pain) on HelloPharmacist
Diclofenac Topical (arthritis pain) on the U.S. market: products, makers and brands
How Diclofenac Topical (arthritis pain) appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
The FDA lists Diclofenac Topical (arthritis pain) products; the earliest marketing or approval year on record is 1988. Brand names on the directory include Pennsaid, Voltaren Arthritis Pain, Surpass Anti-Inflammatory and 10 more; the rest are generics.
How widely Diclofenac Topical (arthritis pain) is used (Medicaid data)
A general measure of how commonly Diclofenac Topical (arthritis pain) is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Diclofenac Topical (arthritis pain) is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Diclofenac Topical (arthritis pain) prescribed? Of the 1,601 medications we measure, Diclofenac Topical (arthritis pain) ranks #44 by Medicaid prescriptions — more than 97% of them.
Utilization by Diclofenac Topical (arthritis pain) product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
diclofenac sodium 0.01 MG/MG Topical Gel Most dispensed
Summed across the 23 of 255 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855633
diclofenac sodium 75 MG Delayed Release Oral Tablet
Summed across the 27 of 346 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855926
diclofenac sodium 50 MG Delayed Release Oral Tablet
Summed across the 19 of 217 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855906
diclofenac sodium 20 MG/ML Topical Solution
Summed across the 8 of 39 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1487074
diclofenac potassium 50 MG Oral Tablet
Summed across the 9 of 138 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855942
diclofenac sodium 0.03 MG/MG Topical Gel
Summed across the 5 of 51 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855642
diclofenac potassium 25 MG Oral Tablet
Summed across the 9 of 24 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 857702
24 HR diclofenac sodium 100 MG Extended Release Oral Tablet
Summed across the 4 of 119 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855657
Twice-Daily diclofenac epolamine 0.013 MG/MG Medicated Patch
Summed across the 1 of 27 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855626
diclofenac sodium 1 MG/ML Ophthalmic Solution
Summed across the 4 of 13 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 854801
diclofenac sodium 25 MG Delayed Release Oral Tablet
Summed across the 4 of 28 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855664
diclofenac sodium 15 MG/ML Topical Solution
Summed across the 2 of 81 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 857700
diclofenac 25 MG Oral Capsule
Summed across the 4 of 17 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 858342
diclofenac potassium 50 MG Powder for Oral Solution
Summed across the 5 of 19 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 859063
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Diclofenac Topical (arthritis pain), and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 124 of 1,374 listed Diclofenac Topical (arthritis pain) NDCs with Medicaid activity.
Diclofenac Topical (arthritis pain) side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Diclofenac Topical (arthritis pain) — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Diclofenac Topical (arthritis pain) in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Diclofenac Topical (arthritis pain) FDA approval history
How Diclofenac Topical (arthritis pain) went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Diclofenac Topical (arthritis pain) recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list 3 Diclofenac recalls since July 2021. All of them are still ongoing or began in the last six months. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51… Lots: Lot # AD92721, Exp Date: 3/31/2027. FDA record D-0342-2026 →
- Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39 Lots: Batch XHBG; Exp. 08/31/2027 FDA record D-0291-2026 →
- Diclofenac Sodium Topical Solution USP, 2% w/w, 3.8 FL.OZ.(112 grams) bottles, Rx only, Manufactured for: Alembic Pharmaceuticals, Inc. Bedminster, NJ 07921, USA Manufactured by: Alembic Pharmaceutic… Lots: Lot #: 220151, 220152, 220153, Exp. Date 11/2024 FDA record D-0941-2023 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 3355 15 dose forms · 30 strengths
-
Dose form (SCDF) Delayed Release Oral Capsule RxCUI 438955No current FDA listingClinical drug / strength (SCD) sodium 25 MGRxCUI 1234844sodium 50 MGRxCUI 1234853 -
Dose form (SCDF) Delayed Release Oral Tablet RxCUI 371794No current FDA listingClinical drug / strength (SCD) sodium 25 MGRxCUI 855664sodium 50 MGRxCUI 855906sodium 75 MGRxCUI 855926 -
Dose form (SCDF) Extended Release Oral Capsule RxCUI 371793No current FDA listingClinical drug / strength (SCD) 24 HR diclofenac sodium 100 MGRxCUI 41184624 HR diclofenac sodium 75 MGRxCUI 411848 -
Dose form (SCDF) Extended Release Oral Tablet RxCUI 371799No current FDA listingClinical drug / strength (SCD) sodium 75 MGRxCUI 85771324 HR diclofenac sodium 100 MGRxCUI 855657 -
Dose form (SCDF) Injectable Solution RxCUI 371795No current FDA listingClinical drug / strength (SCD) sodium 25 MG/MLRxCUI 857705 -
Dose form (SCDF) Medicated Patch RxCUI 1792846No current FDA listingClinical drug / strength (SCD) Once-Daily diclofenac epolamine 0.013 MG/MGRxCUI 2385117Twice-Daily diclofenac epolamine 0.013 MG/MGRxCUI 8556260.0125 MG/MGRxCUI 2705052 -
Dose form (SCDF) Ophthalmic Solution RxCUI 378986No current FDA listingClinical drug / strength (SCD) sodium 1 MG/MLRxCUI 854801 -
Dose form (SCDF) Oral Capsule RxCUI 376352No current FDA listing -
Dose form (SCDF) Oral Solution RxCUI 393225No current FDA listingClinical drug / strength (SCD) sodium 0.25 MG/MLRxCUI 857689 -
Dose form (SCDF) Oral Tablet RxCUI 371798No current FDA listing -
Dose form (SCDF) Powder for Oral Solution RxCUI 1856554No current FDA listingClinical drug / strength (SCD) potassium 50 MGRxCUI 859063 -
Dose form (SCDF) Rectal Suppository RxCUI 371796No current FDA listingClinical drug / strength (SCD) sodium 100 MGRxCUI 857696sodium 12.5 MGRxCUI 857698sodium 25 MGRxCUI 857703sodium 50 MGRxCUI 857709 -
Dose form (SCDF) Topical Cream RxCUI 438948No current FDA listingClinical drug / strength (SCD) sodium 10 MG/MLRxCUI 1043479 -
Dose form (SCDF) Topical Gel RxCUI 377959No current FDA listing -
Dose form (SCDF) Topical Solution RxCUI 393139No current FDA listing
Look up RxCUI 3355 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Diclofenac Topical (arthritis pain) supply and shortage status
Whether Diclofenac Topical (arthritis pain) is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Diclofenac Topical (arthritis pain) brand names
Diclofenac Topical (arthritis pain) is sold under 13 brand names in the FDA directory — Pennsaid, Voltaren Arthritis Pain, Surpass Anti-Inflammatory, Zorvolex and others. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Diclofenac Topical (arthritis pain) drug class (RxNorm)
Diclofenac Topical (arthritis pain) belongs to the Nonsteroidal Anti-inflammatory Drug class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Diclofenac Topical (arthritis pain) page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Proficient Rx LP is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →